Abstract
A distinctive alteration of speech has been reported in patients suffering from ephedrone-induced parkinsonism. However, an objective assessment of dysarthria has not been performed in ephedrone users. We studied 28 young Caucasian men from Georgia with a previous history of ephedrone abuse and compared them to 25 age-matched healthy controls. Speech examination, brain MRI, and NNIPPS-Parkinson plus scale were performed in all patients. The accurate differential diagnosis of dysarthria subtypes was based on the quantitative acoustic analyses of 15 speech dimensions. We revealed a distinct variant of mixed dysarthria with a combination of hyperkinetic and hypokinetic components representing the altered motor programming of dystonia and bradykinesia in ephedrone-induced parkinsonism. According to acoustic analyses, all patients presented at least one affected speech dimension, whereas dysarthria was moderate in 43 % and severe in 36 % of patients. Further findings indicated relationships between motor subscores of dystonia and bradykinesia and speech components of loudness (r = −0.54, p < 0.01), articulation (r = 0.40, p < 0.05), and timing (r = −0.53, p < 0.01). In ephedrone-induced parkinsonism a prominent mixed hyperkinetic–hypokinetic dysarthria occurs that appears related to marked dystonia and bradykinesia and probably reflects manganese induced toxic and neurodegenerative damage to the globus pallidus internus and substantia nigra.
Similar content being viewed by others
References
Albin RL, Young AB, Penney JB (1989) The functional anatomy of basal ganglia disorders. Trends Neurosci 12:366–375
Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571
Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F (1973) Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci 20:415–455
Boersma P, Weenink D (2001) PRAAT, a system for doing phonetics by computer. Glot Int 5:341–345
Butterworth RF, Spahr L, Fontaine S, Layratgues GP (1995) Manganese toxicity, dopaminergic dysfunction and hepatic encephalopathy. Metab Brain Dis 10:259–267
Cersosimo MG, Koller WC (2006) The diagnosis of manganese-induced parkinsonism. Neurotoxicology 27:340–346
Darley FL, Aronson AE, Brown JR (1969) Differential diagnostic patterns of dysarthria. J Speech Hear Res 12:246–269
Dubois B, Slachevsky A, Litvan I, Pillon B (2000) The FAB: a frontal battery at bedside. Neurology 55:1621–1626
Duffy JR (2005) Motor speech disorders: substrates, differential diagnosis and management, 2nd edn. Mosby, New York
Espay AJ, Beaton DE, Morgante F, Gunraj CA, Lang AE, Chen R (2009) Impairment of speed and amplitude of movement in Parkinson’s disease: a pilot study. Mov Disord 24:1001–1008
Fisher E, Goberman AM (2010) Voice onset time in Parkinson’s disease. J Commun Disord 43:21–34
Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinicians. J Psychiatr Res 12:189–198
Graber S, Hertrich I, Daum I, Spieker S, Ackermann H (2002) Speech perception deficits in Parkinson’s disease: underestimation of time intervals compromises identification of durational phonetic contrasts. Brain Lang 82:65–74
Gross C, Rougier A, Guehl D, Boraud T, Julien J, Bioulac B (1997) High-frequency stimulation of the globus pallidus internalis in Parkinson’s disease: a study of seven cases. J Neurosurg 87:491–498
Ho A, Bradshaw J, Iansek R, Alfredson R (1999) Speech volume regulation in Parkinson’s disease: effects of implicit cues and explicit instructions. Neuropsychologia 37:1453–1460
Kataoka R, Warren DW, Zajac DJ, Mayo R, Lutz RW (2001) The relationship between spectral characteristics and perceived hypernasality in children. J Acoust Soc Am 109:2181–2189
Kent RD, Kent JF, Weismer G, Duffy JR (2000) What dysarthrias can tell us about the neural control of speech. J Phonetics 28:273–302
Klos KJ, Ahlskog JE, Josephs KA, Fealey RD, Cowl CT, Kumar N (2005) Neurologic spectrum of chronic liver failure and basal ganglia T1 hyperintensity on magnetic resonance imaging: probable manganese neurotoxicity. Arch Neurol 62:1385–1390
Levin OS (2005) “Ephedron” encephalopathy. Zh Nevrol Psikhiatr Im S S Korsakova 105:12–20 (in Russian)
McNeil MR (1997) Clinical management of sensomotoric speech disorders. Thieme, New York
Mousseau DD, Perney P, Layrargues GP, Butterworth RF (1993) Selective loss of pallidal dopamine D2 receptor density in hepatic encephalopathy. Neurosci Lett 162:192–196
Payan CA, Viallet F, Landwehrmeyer BG, Bonnet AM, Borg M, Durif F et al (2011) Disease severity and progression in progressive supranuclear palsy and multiple system atrophy: validation of the NNIPPS–Parkinson plus scale. PLoS One 6:e22293
Perl DP, Olanow CW (2007) The neuropathology of manganese-induced parkinsonism. J Neuropath Exp Neurol 66:675–682
Rusz J, Cmejla R, Ruzickova H, Ruzicka E (2011) Quantitative acoustic assessment of speech and voice disorders in early untreated Parkinson’s disease. J Acoust Soc Am 129:350–367
Rusz J, Klempir J, Baborova E, Tykalova T, Majerova V, Cmejla R et al (2013a) Objective acoustic quantification of phonatory dysfunction in Huntington’s disease. PLoS One 8:e65881
Rusz J, Cmejla R, Ruzickova H, Klempir J, Majerova V, Picmausova J et al (2013b) Evaluation of speech impairment in early stages of Parkinson’s disease: a prospective study with the role of pharmacotherapy. J Neural Transm 120:319–329
Sanotsky Y, Lesyk R, Fedoryshyn L, Komnatska I, Matviyenko Y, Fahn S (2007) Manganic encephalopathy due to “ephedrone” abuse. Mov Disord 22:1337–1343
Sapir S, Spielman JL, Ramig LO, Story BH, Fox C (2007) Effects of intensive voice treatment (the Lee Silverman voice treatment [LSVT]) on vowel articulation in dysarthric individuals with idiopathic Parkinson disease: acoustic and perceptual findings. J Speech Lang Hear Res 50:899–912
Selikhova M, Fedoryshyn L, Matviyenko Y, Komnatska I, Kyrylchuk M, Krolicki L et al (2008) Parkinsonism and dystonia caused by the illicit use of ephedrone—a longitudinal study. Mov Disord 23:2224–2231
Sikk K, Haldre S, Aquilonius SM, Taba P (2011) Manganese-induced parkinsonism due to ephedrone abuse. Parkinsons Dis 865319. http://www.ncbi.nlm.nih.gov/pubmed/21403909
Skodda S, Flasskamp A, Schlegel U (2010) Instability of syllable repetition as a model for impaired motor processing: is Parkinson’s disease a “rhythm disorder”? J Neural Transm 117:605–612
Stepens A, Logina I, Liguts V, Aldins P, Eksteina I, Platkajis A et al (2008) A parkinsonian syndrome in methcathinone users and the role of manganese. N Engl J Med 358:1009–1017
Zhingel KY, Dovensky W, Crossman A, Allen A (1991) Ephedrone: 2-methylamino-1-phenylpropan-1-one (Jeff). J Forensic Sci 36:915–920
Acknowledgments
We are grateful to H. E. Ivan Jestrab, the Czech Ambassador in Georgia for his personal support, to Nina Mikeladze for neuropsychological testing of patients, to Prof. Jonas Bergquist for testing the manganese content of patient hair, to Prof. Giorgi Menabde for his support, and to Aaron Rulseh, MD for his thoughtful English corrections. This study was supported by the Czech Science Foundation (GACR 102/12/2230), Czech Ministry of Health (NT/12288-5 and NT/14181-3), and Charles University in Prague (PRVOUK-P26/LF1/4 and GA UK 441611). MRI examination in the Research Institute of Clinical Medicine in Tbilisi was enabled by the grant from the Czech Development Agency. JSC Bank Republic Tbilisi supported customs expenses.
Conflict of interest
The authors declare that they have no conflict of interest
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Rusz, J., Megrelishvili, M., Bonnet, C. et al. A distinct variant of mixed dysarthria reflects parkinsonism and dystonia due to ephedrone abuse. J Neural Transm 121, 655–664 (2014). https://doi.org/10.1007/s00702-014-1158-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00702-014-1158-6